
@article{jabir_cholinesterase_2018,
	title = {Cholinesterase targeting by polyphenols: {A} therapeutic approach for the treatment of {Alzheimer}’s disease},
	volume = {24},
	copyright = {© 2018 John Wiley \& Sons Ltd},
	issn = {1755-5949},
	shorttitle = {Cholinesterase targeting by polyphenols},
	url = {http://onlinelibrary.wiley.com/doi/abs/10.1111/cns.12971},
	doi = {10.1111/cns.12971},
	abstract = {Alzheimer’s disease (AD) is a progressive irreversible neurodegenerative disorder characterized by excessive deposition of β-amyloid (Aβ) oligomers, and neurofibrillary tangles (NFTs), comprising of hyperphosphorylated tau proteins. The cholinergic system has been suggested as the earliest and most affected molecular mechanism that describes AD pathophysiology. Moreover, cholinesterase inhibitors (ChEIs) are the potential class of drugs that can amplify cholinergic activity to improve cognition and global performance and reduce psychiatric and behavioral disturbances. Approximately, 60\%-80\% of all cases of dementia in the world are patients with AD. In view of the continuous rise of this disease especially in the aged population, there is a dire need to come up with a novel compound and/or mixture that could work against this devastating disease. In this regard, the best is to rely on natural compounds rather than synthetic ones, because natural compounds are easily available, cost-effective, and comparatively less toxic. To serve this purpose, lately, scientific community has started exploring the possibility of using different polyphenols either solitary or in combination that can serve as therapeutics against AD. In the current article, we have summarized the role of various polyphenols, namely quercetin, resveratrol, curcumin, gallocatechins, cinnamic acid, caffeine, and caffeic acid as an inhibitor of cholinesterase for the treatment of AD. We have also tried to uncover the mechanistic insight on the action of these polyphenols against AD pathogenicity.},
	language = {en},
	number = {9},
	urldate = {2018-10-31},
	journal = {CNS Neuroscience \& Therapeutics},
	author = {Jabir, Nasimudeen R. and Khan, Fayaz Rahman and Tabrez, Shams},
	month = sep,
	year = {2018},
	keywords = {Alzheimer’s disease, cholinesterase, curcumin, gallocatechins, polyphenols, resveratrol},
	pages = {753--762},
	file = {Full Text PDF:/home/lorenzo/Zotero/storage/6B3CYUFZ/Jabir et al. - 2018 - Cholinesterase targeting by polyphenols A therape.pdf:application/pdf;Snapshot:/home/lorenzo/Zotero/storage/6TVT76DJ/cns.html:text/html}
}

@misc{noauthor_acetilcolinesterasi_2018,
	title = {Acetilcolinesterasi},
	copyright = {Creative Commons Attribution-ShareAlike License},
	url = {https://it.wikipedia.org/w/index.php?title=Acetilcolinesterasi&oldid=95436401},
	abstract = {L'acetilcolinesterasi (AChE) è un enzima appartenente alla classe delle idrolasi che catalizza la seguente reazione:
acetilcolina + H2O → colina + acetato
L'enzima è normalmente presente nell'organismo dei mammiferi localizzato nella membrana post-sinaptica delle giunzioni colinergiche. La sua funzione è quella di idrolizzare l'acetilcolina scindendola in colina e acido acetico.
L'attività di questo enzima può essere modificata sia da farmaci, nel trattamento di malattie quali Miastenia gravis e l'Alzheimer, sia da tossine naturali. Per esempio nella diagnosi della miastenia gravis al soggetto viene inoculato un farmaco, la piridostigmina, che con la sua inibizione dell'enzima porta un leggero potenziamento delle facoltà motorie confermando l'ipotesi di diagnosi supposta.},
	language = {it},
	urldate = {2018-10-31},
	journal = {Wikipedia},
	month = mar,
	year = {2018},
	note = {Page Version ID: 95436401},
	file = {Snapshot:/home/lorenzo/Zotero/storage/NHIPJPMF/index.html:text/html}
}

@misc{noauthor_acetilcolina_2018,
	title = {Acetilcolina},
	copyright = {Creative Commons Attribution-ShareAlike License},
	url = {https://it.wikipedia.org/w/index.php?title=Acetilcolina&oldid=99669851},
	abstract = {La molecola della acetilcolina (abbr. ACh, dall'inglese AcetylCholine) è stata il primo neurotrasmettitore a essere individuato. È responsabile in molti organismi, tra cui l'uomo, della trasmissione nervosa sia a livello di Sistema nervoso centrale (SNC) sia di Sistema nervoso periferico (SNP).},
	language = {it},
	urldate = {2018-10-31},
	journal = {Wikipedia},
	month = sep,
	year = {2018},
	note = {Page Version ID: 99669851},
	file = {Snapshot:/home/lorenzo/Zotero/storage/LS5XILF6/index.html:text/html}
}

@article{noauthor_expedient_2017,
	title = {An expedient synthesis of resveratrol through a highly recoverable palladium catalyst},
	volume = {73},
	issn = {0040-4020},
	url = {http://www.sciencedirect.com/science/article/pii/S0040402016308699},
	doi = {10.1016/j.tet.2016.08.074},
	abstract = {A straightforward two-step synthesis of resveratrol is described, with total isolated yields in the range of 75–80\%. The key synthetic step, a Heck–Mi…},
	language = {en},
	number = {38},
	urldate = {2018-10-31},
	journal = {Tetrahedron},
	month = sep,
	year = {2017},
	pages = {5581--5584},
	file = {2017 - An expedient synthesis of resveratrol through a hi.pdf:/home/lorenzo/Zotero/storage/S6B8AWLX/2017 - An expedient synthesis of resveratrol through a hi.pdf:application/pdf;Snapshot:/home/lorenzo/Zotero/storage/6XM24WFB/S0040402016308699.html:text/html}
}

@article{noauthor_design_2017,
	title = {Design, synthesis, and evaluation of multitarget-directed ligands against {Alzheimer}’s disease based on the fusion of donepezil and curcumin},
	volume = {25},
	issn = {0968-0896},
	url = {http://www.sciencedirect.com/science/article/pii/S0968089616315334},
	doi = {10.1016/j.bmc.2017.02.048},
	abstract = {By fusing donepezil and curcumin, a novel series of compounds were obtained as multitarget-directed ligands against Alzheimer’s disease. Among them, c…},
	language = {en},
	number = {12},
	urldate = {2018-10-31},
	journal = {Bioorganic \& Medicinal Chemistry},
	month = jun,
	year = {2017},
	pages = {2946--2955},
	file = {2017 - Design, synthesis, and evaluation of multitarget-d.pdf:/home/lorenzo/Zotero/storage/74VCFJ9H/2017 - Design, synthesis, and evaluation of multitarget-d.pdf:application/pdf;Snapshot:/home/lorenzo/Zotero/storage/N48EECT8/S0968089616315334.html:text/html}
}

@misc{noauthor_world_2018,
	title = {World {Alzheimer} {Report} 2018 {\textbar} {Alzheimer}'s {Disease} {International}},
	url = {https://www.alz.co.uk/research/world-report-2018},
	language = {en},
	urldate = {2018-11-01},
	month = sep,
	year = {2018},
	file = {Snapshot:/home/lorenzo/Zotero/storage/6ZYPKZWR/world-report-2018.html:text/html}
}